ABSTRACT. The effect of acetylsalicylic acid on the cytochrome P-450-mediated fatty acid w-hydroxylation system was assessed in male Sprague-Dawley rats after they were fed a diet containing 1% (w/w) acetylsalicylic acid. A 3-fold increase in the specific activity of laurate w-hydroxylation was observed in the acetylsalicylic acid fed rats in comparison to control rats. This effect of acetylsalicylic acid was unique as the specific activities of other cytochrome P-450-mediated reactions were not increased. The induction of the laurate w-hydroxylation system was also manifested in a rapid formation of its dicarboxylic acid derivative, dodecanedioic acid, as the w-hydroxy derivative was further oxidized by alcohol and aldehyde dehydrogenases. These results suggest the acetylsalicylic acid is similar to other peroxisomal proliferating agents in that it also induces the microsomal fatty acid w-hydroxylation system and may account for the appearance of unique dicarboxylic acids in Reye's syndrome patients. that are ketotic (4) or in individuals that have an impaired fatty acid P-oxidation system such as in glutaric aciduria type I1 (5, 6), ethylmalonic-adipic aciduria (7), systemic carnitine deficiency (8), hypoglycin toxicity (9), acyl-CoA dehydrogenase deficiency (10, 1 l), and in RS (1, 2). The biochemical basis of RS has not been delineated and multiple etiological factors may be responsible for this syndrome (1 1). Fatty acids have been implicated as a factor in RS (1 I). The formation of DCAs is caused by the oxidation of the methyl carbon atom of fatty acids to a carboxyl group and is catalyzed by a series of enzymes that are referred to as the fatty acid w-oxidation system. The initial and rate-limiting step in this sequence of reactions is catalyzed by a microsomal cytochrome P-450-mediated hydroxylase which produces an whydroxy-fatty acid (1 2-14). This derivative is further oxidized by cytosolic alcohol and aldehyde dehydrogenases to form the DCA (15, 16).
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The cytochrome P-450 that catalyzes the w-hydroxylation reaction has considered to be a constitutive, noninducible member of the cytochrome P-450 family of isozymes (17) , but recent studies have demonstrated that clofibrate (18, 19) and DEHP (20, 2 l), potent peroxisomal proliferating agents, are also inducers of the hepatic fatty acid w-hydroxylation system.
ASA has been reported to be another peroxisomal proliferator and inducer of its fatty acid P-oxidation system (22, 23) , but it has not been established if it is an inducer of the microsomal fatty acid w-hydroxylation system. Several studies have indicated that the development of RS is linked to ASA therapy (24) (25) (26) . Because of the possible inductive action of ASA on the whydroxylation system and the observation that DCAs in the serum of RS patients are mitochondrial inhibitors, ASA was administered to rats to determine its effect on the fatty acid whydroxylation system and in the formation of the DCAs using the 12-carbon atom fatty acid, LA, as substrate.
A recent study by Tonsgard and Getz (1) reported that over 50% of the free fatty acids in the serum of RS patients were DCAs and it was postulated that the DCAs were involved in the impairment of mitochondrial function that is associated with this disease. DCAs were observed to uncouple mitochondrial oxidative phosphorylation and to cause mitochondria to lose their condense structure and assume a swollen appearance (1). Ninety percent of the dicarboxylic acids in the RS patients were identified as containing 16-or 18-carbon atoms. Ng et al. (2) initially had reported these unusual long chain DCAs in RS patients in addition to adipic, suberic, and sebacic acids.
DCAs are found in minute quantities in the urine or serum of healthy individuals (3), but they become elevated in individuals MATERIALS AND METHODS Male Sprague-Dawley rats (1 50 g) were purchased from King Animals (Madison, WI) and were fed a standard Purina Rat Chow diet (St. Louis, MO) for 1 or 2 wk to allow them to acclimate to their surroundings. Rats were then placed on an ASA-supplemented diet (1 % w/w of rat food) prepared in pelleted form by Ralston Purina (Richmond, IN) for 2 wk to induce the peroxisomal palmitoyl-CoA oxidation system as described by Ishii and Suga (22) . Control rats were continued on the standard rat Chow. Food was withdrawn 15-to 18-h prior to sacrificing the rats. The microsomal fraction was prepared from livers by the procedures described by Okita et al. (27) . The effects of ASA-feeding on laurate w-or 12-and (a-1)-or 1 l-hydroxylation reactions was examined by the method of Okita and Chance (20) The formation of the DCA derivative, dodecanedioic acid, was assayed in the 17,400 x g liver supernatants of control rats or rats treated with ASA for 2 wk. The reactions were performed in 55 mM potassium phosphate buffer containing 10 mM MgC12, 1 mM NADPH, and 1 mM NAD', 100 KM sodium laurate (Sigma, St. Louis, MO) with 0.1 ~Ci[l-'4C]lauric acid, 8 mM isocitrate (Sigma, St. Louis, MO) with 0.1 mg isocitrate dehydrogenase (Boehringer-Mannheim, Indianapolis, IN), and 5 mg of the 17,400 x g supernatant fraction. The reactions were performed at 37" C for 10 min and the reactions terminated by adding 0.2 ml of 1 N HC1 and extracting with ethylacetate as described by Okita and Chance (20) for the laurate hydroxylation assays. The retention times for the 12-OH and 1 1-OH derivatives of laurate and the DCA were 15.5, 13.8, and 12.7 min, respectively. The identity of the hydroxylated LA derivatives and of the dodecanedioic acid were confirmed by cochromatography with standards using a refractive index monitor and by gas chromatography-mass spectral analysis of the trimethyl silylatedderivatized samples. The 12-OH and dicarboxylic acid derivatives of lauric acid are available from Sigma. The 1 1-OH-LA was produced enzymatically using liver microsomes from phenobarbital-treated rats and a NADPH generating system.
The benzphetamine N-demethylation reaction was performed by the procedure of Werringloer (28) and the ethoxycoumarin and ethoxyresorufin 0-deethylation reactions were assayed by the procedure of Prough et al. (29) . Peroxisomal-mediated palmitoyl-CoA oxidation was examined in liver homogenates (centrifuged at 1090 x g to remove unbroken cells and cell debris) by the procedure of Lazarow (30) . The oxidation of the 12-OH-LA (Sigma) by NAD+-dependent alcohol and aldehyde dehydrogenases was assayed by following the increase in absorbance at 340 nm in the 105,000 x g supernatant fraction (31) . No measurable oxidation of 12-OH-LA was observed using the microsomal fraction, so only the 105,000 xg supernatant was used.
RESULTS
The addition of ASA to the diet of male Sprague-Dawley rats at a concentration of 1 % (w/w) for 1 wk caused a 3-fold stimulation in the peroxisomal mediated, cyanide-insensitive palmitoyl-CoA oxidation system (Table I) . A 3-fold increase in the microsomal cytochrome P-450-mediated LA o-hydroxylase was also observed (Table 1) . These data are consistent with previous reports that peroxisomal proliferating agents also are inducers of the microsomal fatty acid w-hydroxylation system. This ASAmediated induction of the cytochrome P-450 monooxygenase is highly specific for the species that catalyzes the w-hydroxylation of fatty acids, as the feeding of ASA did not stimulate the specific activities of substrates that are metabolized by other isozymes of cytochrome P-450. As shown in Table 2 , the specific activities of benzphetamine N-demethylation, ethoxycoumarin O-deethy- lation, ethoxyresorufin 0-deethylation, and laurate 1 l-hydroxylation were not increased by the ASA feeding. The induction of the cytochrome P-450-mediated o-hydroxylase by ASA caused the rapid utilization of LA and led to the formation of its DCA derivative in assays performed with postmitochondria1 supernatant fractions ( Table 3 ). The postmitochondrial supernatant fraction (1 7,400 x g) from control-fed rats metabolized 35% of the lauric acid in 10 min of which 10% was found as dodecanedioic acid, 20% as 1 I-OH-LA and 5% as 12-OH-LA. In the aspirin-fed rats, only 1% of the radioactivity remained as the unmetabolized lauric acid and 87% was metabolized to the DCA derivative in this time period. These studies demonstrated that aspirin feeding stimulated the formation of the 12-OH-LA and the rapid oxidation to its dicarboxylic acid. The effect of aspirin-feeding on the alcohol and aldehyde dehydrogenases was examined in the 105,000 x g supernatant fraction of control and aspirin-fed rats to determine if these reactions also were induced by ASA-feeding. As shown in Table 4 , the oxidation of 12-OH-LA was stimulated by only 24% in the aspirin-fed rats as compared to control rats and strongly suggests the induction of the cytochrome P-450-dependent w-hydroxylase is responsible for the rapid increase in dicarboxylic acid formation in the aspirin-fed rats.
DISCUSSION
The fatty acid w-hydroxylase is catalyzed by a microsomal cytochrome P-450 which was thought to be a noninducible form of this family of hemeprotein monooxygenases (17) . However, it was reported that hypolipidemic agents that cause the proliferation of hepatic peroxisomes, such as clofibrate and DEHP, are potent inducers of the fatty acid w-hydroxylation system (18) (19) (20) (21) . Because of the reports that ASA was a peroxisomal proliferator (22, 23) , this compound was fed to rats at a dose of 1% (w/w) of their diet. It was observed that ASA-feeding caused a 3-fold increase in laurate 12-hydroxylation without stimulating other known cytochrome P-450-mediated reactions. This in-crease is less than the induction observed for DEHP which is approximately 6-fold over control values (20) . The increase in the w-hydroxylase resulted in a rapid utilization of LA and its conversion to the dicarboxylic acid derivative compared to non-ASA-fed rats. This increase in the formation of dodecanedioic acid is apparently due to the increase in the w-hydroxylase as there was only a minor increase in the dehydrogenation reactions that catalyze the oxidation of 12-OH-LA to the DCA derivative in the ASA-fed rats. Previous studies have established the whydroxylation reaction as the rate-limiting step in the w-oxidation system (14) .
This induction of the w-hydroxylase is of interest because of the recent findings of Tonsgard and Getz (1) and Ng et al. (2) that unique long-chain length dicarboxylic acids are found in the serum of patients with RS and that they are uncouplers of oxidative phosphorylation (I). Passi et al. (32) also reported that short-and medium-chain length (C8-C,,) dicarboxylic acids inhibited mitochondria1 function, but there were differences between these two studies as to the type of rnitochondrial inhibition that was observed. Further evidence of the toxicity of dicarboxylic acids was presented by Mortensen and Gregersen (33) who observed that the administration of hexadecanedioic acid was toxic to starved rats. These studies point to the possible role of dicarboxylic acids in mitochondria1 dysfunction, the development of RS, and the role of ASA in this disease. It would be of interest to determine if RS patients have an induced fatty acid w-hydroxylase. Patients that are diagnosed as having RS but who do not have a history of aspirin therapy should be checked for other agents that may cause the induction of the fatty acid w-hydroxylase, such as DEHP. DEHP is a common plasticizer used in the manufacture of plastics which may migrate from plastic containers and contaminate foods or the water supply (34, 35) . Another compound that may cause peroxisomal proliferation is valproic acid (36), an antiepileptic agent. Peroxisomal proliferation has been noted in some RS patients (37, 38) and it would be interesting to understand the cause of this increase in number of peroxisomes in view of the relationship between compounds that induce the specific activity of the fatty acid w-hydroxylase and cause peroxisomal proliferation.
Although ASA, DEHP, and clofibrate are potent and rapid inducers of the peroxisomal fatty acid p-oxidation and microsoma1 fatty acid w-hydroxylation systems in rodents, it is not known if they have similar effects in humans. Fatty acid hydroxylation is found in human liver microsomes (27) , but the induction of this system in humans has not been studied. The dose of ASA used in this study (1 % w/w of the total diet) was used because of its success in causing rapid peroxisomal proliferation in rats (22) . Further studies are required to establish if pharmacological levels of ASA will induce these enzymic systems in rodent and humans and if arthritic patients who are on ASA therapy have unusual urinary or serum organic acid patterns. The low incidence of individuals who develop RS after a viral infection suggests there may be a genetic predisposition to the effects of ASA or other possible agents that may cause this disease. Further studies are needed to establish the role of the w-hydroxylation system in Reye's patients and the toxicity of dicarboxylic acids on mitochondrial function.
